Novo Nordisk A/S (NYSE: NVO) Faces Earnings Pressure As Investors Weigh Near-Term Outlook

Novo Nordisk A/S (NYSE: NVO) Faces Earnings Pressure As Investors Weigh Near-Term Outlook

Novo Nordisk A/S (NYSE: NVO) has emerged as one of the most searched-for stocks on Zacks.com, drawing significant attention from investors tracking the pharmaceutical sector. Shares of the Danish drugmaker have returned -0.8% over the past month, underperforming the Zacks S&P 500 composite, which posted a gain of +2.1% over the same period. The Zacks Large Cap Pharmaceuticals industry, the category in which Novo Nordisk is grouped, has gained 6.…